Related references
Note: Only part of the references are listed.Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
Shalender Bhasin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Metabolic Changes in Androgen-Deprived Nondiabetic Men With Prostate Cancer Are Not Mediated by Cytokines or aP2
Thiago Gagliano-Juca et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer
Thiago Gagliano-Juca et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2018)
Development of selective androgen receptor modulators (SARMs)
Ramesh Narayanan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer
Thiago Gagliano-Juca et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2018)
Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia
Blanaid M. Hicks et al.
THORAX (2017)
Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer
Blanaid M. Hicks et al.
EPIDEMIOLOGY (2017)
Global Burden of Urologic Cancers, 1990-2013
Geolani W. Dy et al.
EUROPEAN UROLOGY (2017)
Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial
Dennis R. Taaffe et al.
EUROPEAN UROLOGY (2017)
Effect of testosterone and hypoxia on the expansion of umbilical cord blood CD34+ cells in vitro
Liping Zhou et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Association of Testosterone Levels With Anemia in Older Men A Controlled Clinical Trial
Cindy N. Roy et al.
JAMA INTERNAL MEDICINE (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Risk of acute myocardial infarction after androgen-deprivation therapy for prostate cancer in a Chinese population
Jeremy Y. C. Teoh et al.
BJU INTERNATIONAL (2015)
Cardiovascular Disease Associated With Androgen-Deprivation Therapy: Time to Give It Due Respect
Shehzad Basaria
JOURNAL OF CLINICAL ONCOLOGY (2015)
Anemia on admission predicts short- and long-term outcomes in patients with acute ischemic stroke
Haralampos Milionis et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone
Luke A. Beggs et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Anemia in the elderly: clinical implications and new therapeutic concepts
Reinhard Stauder et al.
HAEMATOLOGICA (2014)
Anemia of Inflammation
Elizabeta Nemeth et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point
Eric Bachman et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Identification of erythroferrone as an erythroid regulator of iron metabolism
Leon Kautz et al.
NATURE GENETICS (2014)
Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells
Wen Guo et al.
AGING CELL (2013)
Endothelial function does not relate to haemoglobin or serum erythropoietin concentrations and these do not explain the gender difference in endothelial function in healthy middle-aged men and women
Lindsey Tilling et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Association of anemia with worsened activities of daily living and health-related quality of life scores derived from the Minimum Data Set in long-term care residents
Robert A. Bailey et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2012)
Association Between Sex Steroid Hormones and Hematocrit in a Nationally Representative Sample of Men
Channing J. Paller et al.
JOURNAL OF ANDROLOGY (2012)
Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer
Laurent Azoulay et al.
EUROPEAN UROLOGY (2011)
Reference Ranges for Testosterone in Men Generated Using Liquid Chromatography Tandem Mass Spectrometry in a Community-Based Sample of Healthy Nonobese Young Men in the Framingham Heart Study and Applied to Three Geographically Distinct Cohorts
Shalender Bhasin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
Christopher U. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Testosterone Suppresses Hepcidin in Men: A Potential Mechanism for Testosterone-Induced Erythrocytosis
Eric Bachman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Nancy L. Keating et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Decline of the Red Blood Cell Count in Patients Receiving Androgen Deprivation Therapy for Localized Prostate Cancer: Impact of ADT on Insulin-like Growth Factor-1 and Erythropoiesis
Noboru Hara et al.
UROLOGY (2010)
Serum testosterone levels correlate with haemoglobin in middle-aged and older men
B. B. Yeap et al.
INTERNAL MEDICINE JOURNAL (2009)
Androgens and erythropoiesis: Past and present
S. Shahani et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Association of anemia with clinical outcomes in stable coronary artery disease
Anderson D. da Silveira et al.
CORONARY ARTERY DISEASE (2008)
Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: An inconvenient truth
Shehzad Basaria
JOURNAL OF ANDROLOGY (2008)
Effects of graded doses of testosterone on erythropoiesis in healthy young and older men
Andrea D. Coviello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis
Sadeka Shahani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy
Kathryn Bylow et al.
UROLOGY (2008)
The Regulation of Hepcidin and Its Effects on Systemic and Cellular Iron Metabolism
M. D. Fleming
Hematology-American Society of Hematology Education Program (2008)
Transfusion-dependent anemia after initiation of androgen deprivation therapy for metastatic prostate cancer
Kelly K. Curtis et al.
UROLOGY (2007)
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy
Milena Braga-Basaria et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Low testosterone levels and the risk of anemia in older men and women
Luigi Ferrucci et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?
E Beutler et al.
BLOOD (2006)
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy
S Basaria et al.
CANCER (2006)
Medical progress: Anemia of chronic disease
G Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
M Bolla et al.
LANCET (2002)
Long-term effects of androgen deprivation therapy in prostate cancer patients
S Basaria et al.
CLINICAL ENDOCRINOLOGY (2002)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
CH Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
